Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 17.41 USD -25.47% Market Closed
Market Cap: 284.5m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Biostem Technologies Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biostem Technologies Inc
Total Current Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Biostem Technologies Inc
OTC:BSEM
Total Current Liabilities
$15.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Current Liabilities
$51.8B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
8%
Bristol-Myers Squibb Co
NYSE:BMY
Total Current Liabilities
$22.6B
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Total Current Liabilities
$43.8B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
8%
Merck & Co Inc
NYSE:MRK
Total Current Liabilities
$29.6B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Total Current Liabilities
$24.7B
CAGR 3-Years
22%
CAGR 5-Years
18%
CAGR 10-Years
13%

See Also

What is Biostem Technologies Inc's Total Current Liabilities?
Total Current Liabilities
15.3m USD

Based on the financial report for Dec 31, 2023, Biostem Technologies Inc's Total Current Liabilities amounts to 15.3m USD.

What is Biostem Technologies Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 1Y
127%

Over the last year, the Total Current Liabilities growth was 127%.

Back to Top